In Brief: Blood Products Advisory Committee
This article was originally published in The Gray Sheet
Executive Summary
Blood Products Advisory Committee: Slated to meet June 19 and 20 at the Quality Suites Hotel in Rockville, Maryland. On June 19 the committee will discuss FDA's recommendation for the reclassification of automated infectious disease test systems used for donor screening and Class I medical devices used in the collection and processing of blood. On June 20 the committee will discuss the inadvertent contamination of plasma used for fractionation. For more information, contact FDA's Linda Smallwood at 301/827-3514...